Video Experimental Relacionado
Updated: May 24, 2026
08:27
Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
Published on: July 29, 2018
Los mecanismos de Alzheimer y las estrategias terapéuticas
1Gladstone Institute of Neurological Disease, San Francisco, CA 94158, USA.
Cell
|March 20, 2012
Resumen
Los tratamientos efectivos para la enfermedad de Alzheimer siguen siendo escurridizos, pero décadas de investigación revelan sus complejas causas genéticas y mecanismos moleculares. La investigación diversificada es clave para desarrollar nuevas terapias para esta condición multifactorial.
Área de la Ciencia:
- La neurociencia es la neurociencia.
- Genética La genética.
- Farmacología Farmacología.
Sus antecedentes:
- La enfermedad de Alzheimer (EA) carece actualmente de tratamientos preventivos o curativos efectivos.
- Décadas de investigación han iluminado la naturaleza compleja y multifactorial de la patogénesis de la EA.
- Los avances significativos en la comprensión de la enfermedad de Alzheimer están surgiendo de los esfuerzos de investigación interdisciplinaria.
Objetivo del estudio:
- Para revisar los avances recientes de la investigación en la enfermedad de Alzheimer.
- Para resaltar la importancia de los enfoques interdisciplinarios en la comprensión de AD.
- Hacer hincapié en la necesidad de estrategias diversificadas de desarrollo de fármacos.
Principales métodos:
- Estudios genéticos para identificar las causas de las enfermedades.
- Bioquímica, biología molecular y celular, y modelado transgénico para dilucidar los mecanismos moleculares.
- Química, radiología y biología de sistemas para el descubrimiento de biomarcadores.
Principales resultados:
- Los estudios genéticos confirman la etiología multifactorial de la enfermedad de Alzheimer.
- La investigación interdisciplinaria ha revelado mecanismos moleculares clave que subyacen a la enfermedad de Alzheimer.
- Los avances en el descubrimiento de biomarcadores y la medicina personalizada están transformando la investigación de la enfermedad de Alzheimer.
- La investigación actual apunta hacia el potencial de futuros avances terapéuticos.
Conclusiones:
- La enfermedad de Alzheimer es una condición compleja con múltiples factores contribuyentes.
- La investigación interdisciplinaria y el desarrollo diversificado de fármacos son cruciales para abordar la enfermedad de Alzheimer.
- Las tecnologías emergentes y la medicina personalizada ofrecen nuevas vías para el tratamiento y los ensayos clínicos.
- La inversión continua en diversos enfoques de investigación es esencial para combatir la enfermedad de Alzheimer.
Videos de Conceptos Relacionados
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.